Cargando…
P1233: PRIMARY REFRACTORY PLASMABLASTIC LYMPHOMA: A PRECISION ONCOLOGY APPROACH
Autores principales: | Witte, H., Fähnrich, A., Riedl, J., Kuenstner, A., Hertel, N., von Bubnoff, N., Merz, H., Busch, H., Feller, A., Gebauer, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430318/ http://dx.doi.org/10.1097/01.HS9.0000847796.45905.ad |
Ejemplares similares
-
Primary refractory plasmablastic lymphoma: A precision oncology approach
por: Witte, Hanno M., et al.
Publicado: (2023) -
P1232: PRINCIPLES OF PRECISION ONCOLOGY IN PRIMARY REFRACTORY HIGH-GRADE B-CELL LYMPHOMA WITH MYC-, BCL2 AND/OR BCL6 REARRANGEMENTS (HGBL-DH/TH)
por: Witte, H., et al.
Publicado: (2022) -
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
por: Hertel, Nadine, et al.
Publicado: (2021) -
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
por: Witte, Hanno M., et al.
Publicado: (2022) -
Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients
por: Witte, Hanno M., et al.
Publicado: (2020)